Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Core Insights - Jazz Pharmaceuticals plc will participate in Citi's 2025 Global Healthcare Conference with a fireside chat scheduled for December 2, 2025 [1][2]. Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on innovating to transform the lives of patients with serious diseases, often with limited therapeutic options [3]. - The company has a diverse portfolio that includes leading therapies for sleep disorders and epilepsy, as well as a growing range of cancer treatments [3]. - Jazz is headquartered in Dublin, Ireland, and has research and development laboratories, manufacturing facilities, and employees in multiple countries [3].